Academic Journal
Q4Vascular Cell
About Vascular Cell
About Vascular Cell
Vascular Cell is a peer-reviewed scholarly journal published by Publiverse Online srl (United Kingdom). It focuses on Q4. Publication coverage spans 2011-2021, 2023, 2025.
Key indicators: ISSN 2045-824X; H-index 40.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (40): 40 articles have each received at least 40 citations, indicating growing recognition.
Publishing in Vascular Cell
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q4. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Vascular Cell?
2045-824X.
Who publishes Vascular Cell?
Publiverse Online srl.
What are Vascular Cell's metrics?
H-index 40.
Is Vascular Cell peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Angiogenesis and VEGF in Cancer; Cell Adhesion Molecules Research; Lymphatic System and Diseases; Developmental Biology and Gene Regulation; Cancer, Hypoxia, and Metabolism; Immune cells in cancer.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Hemangioblastoma: an updated primer
Andrew Penner, Antonia Gambino, Ana-Maria Burlea, Tamanna Sarowar et al.
2025-10-03 · DOI: 10.24238/13221-15-1-227A 3-Dimensional Hypothesis of Oxidative Phosphorylation
Vincent A Knight
2023-03-27 · DOI: 10.24238/13221-14-1-215The long and winding road: detecting and quantifying Notch activation in endothelial cells
Lydia L Wu, Stephanie Shen, Henry Biermann, Mildred Nelson et al.
2021-12-31 · DOI: 10.24238/13221-13-1-201Angiogenesis-osteogenesis coupling: a key element in bone physiology and regeneration
Bridget Boston, Deepak Ipe, Bogdan Capitanescu, Stephen Hamlet et al.
2021-12-31 · DOI: 10.24238/13221-13-1-203Vascular Tumors Result from Adeno-Associated Virus-9 Angiogenic Gene Therapy of Bone Allografts
Elisa S. Rezaie, Noortje J. Visser, Roman Thaler, Farzaneh Khani et al.
2020-11-16 · DOI: 10.24238/13221-12-1-192A clinically relevant model of stroke using aged rats
Aurel Popa-Wagner, Mircea Popescu-Driga, Leonard-Radu Pinosanu, Monica Grigore et al.
2020-11-16 · DOI: 10.24238/13221-12-1-198The SARS-CoV2 - ACE2 link: a physiopathological analysis
Eugen B Petcu, Christopher Andry, Eric J Burks, Stephen Hamlet et al.
2020-08-03 · DOI: 10.24238/13221-12-1-197External Quality Assessments of CD31 Immunoassays – the NordiQC experience
Mogens Vyberg, Søren Nielsen, Michael Bzorek, Rasmus Røge et al.
2020-07-30 · DOI: 10.24238/13221-12-1-193Multidisciplinary approach to maximize angiogenesis and wound healing using piezoelectric surgery, concentrated growth factors and photobiomodulation for dental implant placement surgery involving lateral wall sinus lift: two case reports.
Doan Nghiem V, Huynh Thang Q, Tran Sang, Wang Gui et al.
2020-04-28 · DOI: 10.24238/13221-12-1-186Surgical angiogenesis for scaphoid non-union: a literature review
Jamie Corcoran, Usama Zafar, Iulian Nusem
2020-01-11 · DOI: 10.24238/13221-12-1-187An Improved In Vivo Angiogenesis Model of Chicken Chorioallantoic Membranes in Surrogate Shells Revealed the Pro-angiogenesis Effects of Chylomicrons
Xiao Wan, Zifu Zhang, Lei Rui, Rhodri S. Wilson et al.
2019-02-25 · DOI: 10.24238/13221-11-1-178The Challenges of Implementing a PD-L1 Proficiency Testing Program in Australia
Julia Pagliuso, Suzanne Parry, Zenobia Haffajee, Tony Badrick et al.
2018-12-28 · DOI: 10.24238/13221-10-1-180An update on angiogenesis modulators with a potential therapeutic role
Christopher Philippa, Rodica Ileana Miroiu, Mark Slevin, Eugen Bogdan Petcu et al.
2018-12-22 · DOI: 10.24238/13221-10-1-179Development of an ImageJ-based method for analysing the developing zebrafish vasculature
Victoria A. Simms, Roy Bicknell, Victoria L. Heath
2017-12-15 · DOI: 10.24238/13221-9-1-172An ectopic intramedullary hematopoietic niche in a cervical spine meniscoid: a case report
Scott F. Farrell, Eugen B. Petcu, Jon Cornwall, Darren A. Rivett et al.
2017-12-15 · DOI: 10.24238/13221-9-1-173Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’
L. Christian Napp, Olga Jabs, Anna Höckelmann, Jochen Dutzmann et al.
2017-12 · DOI: 10.1186/s13221-016-0039-1Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice
L. Christian Napp, Olga Jabs, Anna Höckelmann, Jochen Dutzmann et al.
2016-12 · DOI: 10.1186/s13221-016-0038-2Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells
Valentina Ceserani, Anna Ferri, Angiola Berenzi, Anna Benetti et al.
2016-12 · DOI: 10.1186/s13221-016-0037-3A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model
Laura Paneghetti, Yin-Shan Eric Ng
2016-12 · DOI: 10.1186/s13221-016-0036-4A novel mutation in CELSR1 is associated with hereditary lymphedema
M. L. Gonzalez-Garay, M. B. Aldrich, J. C. Rasmussen, R. Guilliod et al.
2016-12 · DOI: 10.1186/s13221-016-0035-5Reviews
Community Reviews
Version History
October 10, 2026 at 2:01 pm
October 2, 2026